Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Mitoxantrone recalled?

Not under an active recall. Mitoxantrone was recalled 3 times in the past — all now closed. Most recent: Sep 13, 2016.

Most common reason: Impurity / degradation (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Mitoxantrone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Mitoxantrone recalls on record

none so far in 2026; 3 on record, newest first
Class III · Low risk

mitoXANTRONE Injection USP

Failed Impurities/Degradation Specifications: potential failure to meet the specification for Impurity D throughout shelf-life.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0703-4685-01 D-0095-2017
Class III · Low risk

mitoXANTRONE Injection USP

Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.

Terminated Impurity / degradation Teva North America NDC 0703-4685-01 D-1451-2016
Class I · High risk

MitoXANTRONE Injection

Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.

Terminated Stability / shelf life Hospira Inc. D-0433-2015